SwatiPadmakarToleMD

Internal Medicine • Stanford, CA

Physician

Join to view full profile

Dr. Tole is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tole's full profile

Already have an account?

Office
117 Encina Commons
Stanford University
Stanford, CA 94305
Phone+1 650-723-2217

Education & Training

University of California (San Francisco)Residency, Internal Medicine, 1999 - 2002
University of California San Francisco School of MedicineClass of 1999

Clinical Trials

A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE) Start of enrollment: 2007 Jan 01
Completed

Publications & Presentations

PubMed

56 citations
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti‐integrin therapies
Iris Dotan, Matthieu Allez, Silvio Danese, Mary E. Keir, Swati Tole
Medicinal Research Reviews. 2020-01-01
47 citations
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.
Silvio Danese, Jean-Frederic Colombel, Milan Lukas, Javier P Gisbert, Geert R. D'Haens
The Lancet. Gastroenterology & Hepatology. 2021-11-16
53 citations
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, ran...
Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, Millie D. Long, Matthieu Allez
The Lancet. Gastroenterology & Hepatology. 2021-11-17

Press Mentions

Female Founded and Funded Capsida Taps Swati Tole as Chief Medical OfficerJune 1st, 2021